Dolby Laboratories, Inc.
DLB
$70.67
-$1.30-1.81%
NYSE
12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
---|---|---|---|---|---|
Net Income | 15.80% | 52.35% | -60.70% | 46.06% | 629.16% |
Total Depreciation and Amortization | 3.34% | 14.98% | 2.07% | -0.87% | -13.59% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 24.00% | 55.03% | -48.49% | 20.54% | -51.70% |
Change in Net Operating Assets | -210.45% | 122.38% | -245.77% | 135.19% | -2,026.41% |
Cash from Operations | -8.08% | 446.32% | -88.28% | 2,057.32% | -90.11% |
Capital Expenditure | 8.13% | 3.07% | 14.61% | -46.19% | 25.49% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | 99.72% | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | 178,686.26% | 98.54% | -233.05% | 158.41% |
Cash from Investing | 96.88% | -3,274.33% | 56.67% | -2,923.54% | 103.21% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 2,994.55% | -92.94% | -8.17% | -41.94% | 80.31% |
Repurchase of Common Stock | -119.13% | 40.48% | -37.32% | 76.88% | -316.22% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -10.28% | 0.33% | 0.05% | -0.57% | -10.57% |
Other Financing Activities | 93.00% | -205.69% | -- | 100.00% | -- |
Cash from Financing | 4.24% | -2.95% | -32.23% | 64.71% | -192.40% |
Foreign Exchange rate Adjustments | -263.37% | 611.55% | 76.69% | -154.15% | 283.56% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 116.88% | -339.24% | -139.53% | 205.85% | -681.21% |